Sep 11, 2022 09:00PM
Sep 6, 2022 09:26PM
Aug 31, 2022 09:00PM
Aug 26, 2022 09:00PM
Aug 21, 2022 09:00PM
Aug 15, 2022 09:00PM
Aug 10, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Missfresh, Molecular Partners, TG Therapeutics, and 17EdTech and Encourages Investors to Contact the Fi
Aug 5, 2022 09:00PM
Jul 31, 2022 09:00PM
Jul 25, 2022 09:00PM
Jul 20, 2022 09:00PM
Jul 15, 2022 09:00PM
Jul 10, 2022 09:00PM
Jul 4, 2022 09:00PM Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, Allianz, Outset Medical, and TrueBlue and Encourages Investors to Contact the Firm
Jun 29, 2022 09:00PM
Jun 24, 2022 09:00PM
Jun 19, 2022 09:00PM
Jun 13, 2022 09:00PM
Jun 8, 2022 09:00PM
Jun 3, 2022 09:00PM
May 22, 2022 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm
May 16, 2022 09:00PM
Apr 15, 2022 08:31AM
Apr 15, 2022 08:30AM
Mar 10, 2022 08:16AM
Mar 10, 2022 08:15AM
Mar 3, 2022 08:00AM
Mar 3, 2022 08:00AM TG Therapeutics Announces Extension of U.S. FDA BLA/sNDA PDUFA Date for Ublituximab Plus UKONIQ® (U2) to Treat Patients with CLL and SLL
Mar 1, 2022 07:31AM
Mar 1, 2022 07:30AM
Jan 27, 2022 10:21AM
Dec 27, 2021 09:00PM
Dec 22, 2021 09:00PM
Dec 14, 2021 07:15AM
Dec 14, 2021 07:15AM TG Therapeutics Announces FDA Acceptance of Biologics License Application for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis
Dec 2, 2021 10:02PM
Nov 30, 2021 08:54AM
Nov 30, 2021 07:33AM
Nov 30, 2021 07:30AM
May 25, 2021 07:03AM
May 25, 2021 07:00AM
Aug 13, 2020 07:04AM TG Therapeutics (TGTX) Announces FDA Acceptance of NDA for Umbralisib as Treatment for Patients with Previously Treated Marginal Zone Lymphoma and Follicular Lymphoma
Aug 13, 2020 07:00AM
May 8, 2020 07:00AM

15,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All